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Fig. 1 – Relative frequency distribution of HCV subtypes in
Pakistan. * Subtype not deﬁned (a) and province-wise
distribution pattern of major HCV genotypes (b).pointing out a forthcoming  pro
Dear Editor,
A recent article by Gul et al.1 highlights an important issue of
Hepatitis C Virus (HCV) subtypes sero-prevalence in the Khy-
ber Pakhtunkhwa (KPK) province of Pakistan. It is the ﬁrst
report of its kind on the changing epidemiological pattern
of HCV genotypes in the province. The results of the study
showed an increase in mixed HCV subtypes (22.9%) and geno-
type 1a (11.6%) and decrease in 3a genotype (45.5%).1 The
outcome of interferon plus ribavirin therapy is viral genotype
speciﬁc, some genotypes/subtypes being good responders
while others are not. Keeping in view the importance of
sero-prevalent viral genotype regarding the management of
patients, we  analyzed the previous reports (26 published stud-
ies) from Pakistan on prevalence of HCV genotypes. The
existing data showed that genotype 3a (57.37) is the most
common genotype in the country while the prevalence of 1b
subtype is only 1.985% and 1a is 5.93% (Fig. 1a), which support
the study by Gul et al.1 The analysis of previous published
results regarding province wise distribution of the viral geno-
types showed that 3a is the major circulating viral genotype in
all four provinces of the country but the distribution of other
viral clades is differential (Fig. 1b). By comparing the previ-
ously published results with the current report by Gul et al. it
is evident that the pattern of HCV subtypes is changing in the
region.
Due to the error prone nature of viral polymerase, HCV
has many  genotypes and subtypes. The interferon therapy
response is genotype dependent and different viral genotypes
showed varied level of sustained virological response (SVR).
Among all viral genotypes 3a has shown to be a good respon-
der to interferon therapy.2 Pakistan is a resource constrained
country with very low per capita income and considerably low
expenditure on health by the Government (just 2.7% of GDP).3
It ranked second in the world in terms of HCV infection with
more than 10 million infections.3 As the data indicates that
3a, supposedly to be a good responder to therapy, is the most
prevalent genotype in the country most of the treated individ-
uals with interferon therapy should attain SVR. Accordingly,
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 most recent report (2014) from Pakistan regarding response
f different HCV genotypes to interferon therapy showed 95%
VR in 3a infections in contrast to only 34% of 1b infections.4
he current shift in the circulating viral genotype enlighten
n important upcoming danger. Health care workers may face
roblems to successfully treat patients as it will be more  difﬁ-
ult for patients to achieve SVR. For achieving higher rates of
VR antiviral therapy will have to be extended thus increas-
ng the economic burden on society and psychology trauma on
he patients and their families. SVR rates are greatly increased
ith direct acting antivirals (DAA) therapy but the high cost is
 major obstacle.5 In Pakistan, the allocated budget for health
s already pretty low and the country is also endemic for other
iral infections like polio and dengue which would result in
hifting of priorities. By viewing the forthcoming giant of HCV
herapy resistance, it is needed to properly monitor the pattern
f HCV genotypes in the country. A well developed surveil-
ance system is highly needed to timely tackle the upcoming
roblem.
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